About Us
Translating Science into Preclinical Success
Truly was founded on the principle that preclinical drug development is best optimized through a robust translational approach. With our deep expertise, we help accelerate our customers’ preclinical projects.
Founded in 2011, Truly Translational was built on a foundation of scientific expertise, backed by nearly a century of combined experience in drug research and development from major pharmaceutical companies and biotech innovators. As we grew, we launched Truly Labs in 2015 as a subsidiary of Truly Translational, broadening our offerings to include comprehensive lab services.
The Truly team brings a strong track record of both strategic insight and experimental expertise, supporting clients from early preclinical in vitro studies and animal models through to biomarker-driven strategies and proof-of-concept testing in clinical studies. We understand that a blend of translational knowledge and rigorous research is essential to transform preclinical development into clinical success.
Our inclusive, supportive company culture is at the heart of what we do. By fostering close collaboration, open communication, and flexibility, we aim to deliver high-quality, tailored services that meet your specific needs and timelines. At Truly, we see ourselves as an extension of your team, committed to helping you achieve your project goals efficiently and effectively.